Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• The natural killer group 2 member D (NKG2D) receptor and its ligands (NKG2DLs) are central to innate immune responses mediated by NK, γδ, and CD8+ T cells.
• NKG2DL expression is upregulated on stressed, virally infected, or transformed cells, marking them for immune attack.
• Viruses and cancer cells frequently downregulate NKG2DLs to evade immune surveillance and cytotoxicity.

Purpose of the Study:

• To investigate the convergent mechanisms used by viruses and cancer cells to suppress NKG2D ligand expression.
• To identify shared regulatory pathways in immune evasion strategies employed by pathogens and tumors.
• To explore therapeutic opportunities targeting these common immune evasion mechanisms.

Main Methods:

• Comparative analysis of molecular pathways regulating NKG2DL expression in viral infections and cancer.
• Examination of immune evasion strategies at the level of gene regulation and protein expression.
• Literature review and synthesis of existing data on NKG2D-NKG2DL interactions.

Main Results:

• Identified conserved mechanisms of immune evasion involving the downregulation of NKG2DLs by both viruses and cancer cells.
• Highlighted convergent evolution in the regulation of NKG2DL expression and subsequent immune responses.
• Demonstrated that targeting shared regulatory steps could overcome immune evasion.

Conclusions:

• Viruses and cancer cells utilize similar strategies to evade NKG2D-mediated immunity by suppressing NKG2DLs.
• Understanding these shared pathways offers potential for novel therapeutic interventions, such as oncolytic virotherapy.
• Targeting common immune evasion mechanisms can potentially restore innate immune surveillance against cancer and infections.